Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection중증 급성 호흡기 증후군 코로나바이러스 2 감염 환자의 비혈장 구획에서 프로드럭 Molnupiravir의 모체 뉴클레오사이드인 ß-d-N4-Hydroxycytidine의 약동학Clinical Trial Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] [DOI] 10.1093/cid/ciac199 PMC 바로가기 [Article Type] Clinical Trial
A validated LC-MS/MS method for determination of antiviral prodrug molnupiravir in human plasma and its application for a pharmacokinetic modeling study in healthy Egyptian volunteers인간 혈장에서 항 바이러스 전구 약물 Molnupiravir의 결정을위한 검증 된 LC-MS/MS 방법 및 건강한 이집트 자원 봉사자들의 약동학 적 모델링 연구에 대한 적용Article Published on 2022-08-152022-08-31 Journal: Journal of chromatography. B, Analytical technolog [Category] [DOI] 10.1016/j.jchromb.2022.123363 PMC 바로가기 [Article Type] Article
SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation예방 접종 또는 감염 후 유도된 SARS-CoV-2 스파이크 및 핵단백질 특이적 항체는 고전적 보체 활성화를 촉진합니다Article Published on 2022-07-042022-09-11 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.838780 PMC 바로가기 [Article Type] Article
Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral ActivityCOVID-19에 대한 Molnupiravir 용도 변경: 항바이러스 활성 메커니즘Review Published on 2022-06-202022-09-11 Journal: Viruses [Category] [DOI] 10.3390/v14061345 PMC 바로가기 [Article Type] Review
Molnupiravir; molecular and functional descriptors of mitochondrial safety몰누피라비르; 미토콘드리아 안전성의 분자 및 기능 설명자Article Published on 2022-05-012022-09-11 Journal: Toxicology and applied pharmacology [Category] [DOI] 10.1016/j.taap.2022.116003 PMC 바로가기 [Article Type] Article
The pill of recovery; Molnupiravir for treatment of COVID-19 patients; a systematic reviewResearch article Published on 2022-05-012022-10-05 Journal: Saudi Pharmaceutical Journal : SPJ [Category] [DOI] 10.1016/j.jsps.2022.03.002 [Article Type] Research article
Composition, Clinical Efficiency, and Mechanism of NHC-Approved “Three Chinese Medicines and Three Chinese Recipes” for COVID-19 TreatmentPharmacology Published on 2022-02-042022-10-31 Journal: Frontiers in Pharmacology [Category] [DOI] 10.3389/fphar.2021.781090 PMC 바로가기 [Article Type] Pharmacology
The Potential Bioactive Components of Nine TCM Prescriptions Against COVID-19 in Lung Cancer Were Explored Based on Network Pharmacology and Molecular DockingMedicine Published on 2022-01-202022-10-31 Journal: Frontiers in Medicine [Category] [DOI] 10.3389/fmed.2021.813119 PMC 바로가기 [Article Type] Medicine
Signaling Potential Therapeutic Herbal Medicine Prescription for Treating COVID-19 by Collaborative FilteringPharmacology Published on 2021-12-242022-10-31 Journal: Frontiers in Pharmacology [Category] [DOI] 10.3389/fphar.2021.759479 PMC 바로가기 [Article Type] Pharmacology
Metallodrug Profiling against SARS‐CoV‐2 Target Proteins Identifies Highly Potent Inhibitors of the S/ACE2 interaction and the Papain‐like Protease PL proFull Paper Published on 2021-11-232022-10-31 Journal: Chemistry (Weinheim an Der Bergstrasse, Germany) [Category] [DOI] 10.1002/chem.202103258 PMC 바로가기 [Article Type] Full Paper